---
title: "Ocugen Inc. Stock Falls Thursday, Underperforms Market"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295147909.md"
description: "Ocugen Inc. (OCGN) shares fell 3.13% to $1.24 on Thursday, underperforming the broader market as the S&P 500 and Dow Jones also declined. This marks the stock's second consecutive day of losses. Ocugen is currently trading 54.50% below its 52-week high of $2.73 reached in March. Trading volume was lower than the 50-day average."
datetime: "2026-08-06T21:30:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295147909.md)
  - [en](https://longbridge.com/en/news/295147909.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295147909.md)
---

# Ocugen Inc. Stock Falls Thursday, Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Ocugen Inc. (OCGN) shed 3.13% to $1.24 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.18% to 7,709.96 and Dow Jones Industrial Average falling 0.85% to 53,885.10.

This was the stock's second consecutive day of losses.

Ocugen Inc. closed 54.50% short of its 52-week high of $2.73, which the company reached on March 17th.

Trading volume (5.6 M) remained 1.6 million below its 50-day average volume of 7.1 M.

Data source: Dow Jones Market Data, FactSet. Data compiled August 6, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

08-06-26 1730ET

### Related Stocks

- [OCGN.US](https://longbridge.com/en/quote/OCGN.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [SPY.US](https://longbridge.com/en/quote/SPY.US.md)
- [IVV.US](https://longbridge.com/en/quote/IVV.US.md)
- [VOO.US](https://longbridge.com/en/quote/VOO.US.md)
- [SPLG.US](https://longbridge.com/en/quote/SPLG.US.md)
- [SPXL.US](https://longbridge.com/en/quote/SPXL.US.md)
- [UPRO.US](https://longbridge.com/en/quote/UPRO.US.md)
- [SSO.US](https://longbridge.com/en/quote/SSO.US.md)
- [SH.US](https://longbridge.com/en/quote/SH.US.md)
- [SPXS.US](https://longbridge.com/en/quote/SPXS.US.md)
- [SPXU.US](https://longbridge.com/en/quote/SPXU.US.md)
- [SDS.US](https://longbridge.com/en/quote/SDS.US.md)
- [SPYI.US](https://longbridge.com/en/quote/SPYI.US.md)
- [JEPI.US](https://longbridge.com/en/quote/JEPI.US.md)
- [XYLD.US](https://longbridge.com/en/quote/XYLD.US.md)
- [DIA.US](https://longbridge.com/en/quote/DIA.US.md)
- [DDM.US](https://longbridge.com/en/quote/DDM.US.md)
- [UDOW.US](https://longbridge.com/en/quote/UDOW.US.md)
- [DOG.US](https://longbridge.com/en/quote/DOG.US.md)
- [SDOW.US](https://longbridge.com/en/quote/SDOW.US.md)
- [DXD.US](https://longbridge.com/en/quote/DXD.US.md)
- [MKTW.US](https://longbridge.com/en/quote/MKTW.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Ocugen Targets 2027 BLA Filings as Gene Therapy Programs Near Key Readouts](https://longbridge.com/en/news/296009571.md)
- [OCGN: Pivotal gene therapy trials for RP and Stargardt aim for global launches by 2028](https://longbridge.com/en/news/295568730.md)
- [LIVE MARKETS-From inflation fears to growth fears](https://longbridge.com/en/news/295427746.md)
- [Stocks See Support as Weak US Economic Reports Curb Fed Rate-Hike Expectations](https://longbridge.com/en/news/295946665.md)
- [GRAPHIC-U.S. equity funds draw inflows as rate-hike concerns ease](https://longbridge.com/en/news/295935286.md)